CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians.
about
Sequence diversity and haplotype structure at the human CYP3A clusterReview of studies on metabolic genes and cancer in populations of African descent.The frameshift polymorphism CYP3A43_74_delA is associated with poor differentiation of breast tumors.Polymorphisms in hOGG1 and XRCC1 and risk of prostate cancer: effects modified by plasma antioxidants.Mutational landscape of candidate genes in familial prostate cancerPolymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk.Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population.Clinical implications of CYP3A polymorphisms.Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.Constitutional polymorphisms of prostate cancer: prognostic and diagnostic implications.Genetic variation in CYP3A43 is associated with response to antipsychotic medication.Molecular basis for prostate cancer racial disparities.Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese MenJoint effects of inflammation and androgen metabolism on prostate cancer severity.Plasma carotenoids and prostate cancer: a population-based case-control study in Arkansas.Ancestry-Adjusted Vitamin D Metabolite Concentrations in Association with Cytochrome 3A (CYP3A) Polymorphisms.
P2860
Q28284189-0F85278A-9C28-4B5E-9107-2F5EB9FE9244Q30494890-F4CDAD15-FE75-45CC-9F07-D3353E145575Q33660484-FD9F88D4-DDA9-4F8E-9360-84B62DAC5AE5Q33774556-EFF10BA1-8188-41B3-BC23-41FE25F9F5F9Q34079517-C2EBEAC9-3B84-4AD7-8279-295B8B876132Q35516448-908F71BB-803B-4ABA-911C-5C9D9A0BBE32Q36293101-26F4A755-B631-43FB-8C28-BE012E726281Q36546247-CD281A98-18D1-4449-85C7-0D2A75E7CD4EQ36758880-FE979718-E0E9-4F67-B168-A91035FE7B35Q37016023-E1AAD15D-3923-44E9-92D2-1EA22965ED16Q38242595-1A489D12-FC94-45A6-A0B7-3EFB36435CEFQ41334556-81AA510A-584E-4A79-8245-A43DFA7AC549Q41884768-463CC6F1-B104-4E41-8987-05A5AA2D30C2Q41931088-01D02E9F-46A0-4F37-8327-D60CE5B8CE6CQ46957678-9B1FF7C8-B9E4-403B-A0FA-48A234B6F888Q50548159-A5C28627-3C32-40CE-BB42-97C072928E40
P2860
CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
CYP3A43 Pro
@nl
CYP3A43 Pro(340)Ala polymorphi ...... ican Americans and Caucasians.
@ast
CYP3A43 Pro(340)Ala polymorphi ...... ican Americans and Caucasians.
@en
type
label
CYP3A43 Pro
@nl
CYP3A43 Pro(340)Ala polymorphi ...... ican Americans and Caucasians.
@ast
CYP3A43 Pro(340)Ala polymorphi ...... ican Americans and Caucasians.
@en
prefLabel
CYP3A43 Pro
@nl
CYP3A43 Pro(340)Ala polymorphi ...... ican Americans and Caucasians.
@ast
CYP3A43 Pro(340)Ala polymorphi ...... ican Americans and Caucasians.
@en
P2093
P1476
CYP3A43 Pro(340)Ala polymorphi ...... ican Americans and Caucasians.
@en
P2093
Al A Rasheed
Alindria Carroll
Angie Stone
Don E Johnson
Fred F Kadlubar
Gail Runnells
Ginny L Emerson
Graham Greene
Luke D Ratnasinghe
Nicholas P Lang
P304
P356
10.1158/1055-9965.EPI-04-0534
P577
2005-05-01T00:00:00Z